Nuvation Bio Inc (NYSE:NUVB) has a beta value of 1.37 and has seen 7.9 million shares traded in the last trading session. The company, currently valued at $690.74M, closed the last trade at $2.03 per share which meant it gained $0.06 on the day or 3.05%% during that session. The NUVB stock price is -95.57% off its 52-week high price of $3.97 and 24.14% above the 52-week low of $1.54. If we look at the company’s 10-day average daily trading volume, we find that it stood at 10.73 million shares traded. The 3-month trading volume is 4.74 million shares.
The consensus among analysts is that Nuvation Bio Inc (NUVB) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 4 have rated it as a Hold, with 4 advising it as a Buy. 0 have rated the stock as Underweight.
Nuvation Bio Inc (NYSE:NUVB) trade information
Over the past 30 days, the shares of Nuvation Bio Inc (NYSE:NUVB) have changed 0.00%. Short interest in the company has seen 42.33 million shares shorted with days to cover at 10.4.
Wall Street analysts have a consensus price target for the stock at $6, which means that the shares’ value could jump 66.17% from current levels. The projected low price target is $6.0 while the price target rests at a high of $6.0. In that case, then, we find that the current price level is -195.57% off the targeted high while a plunge would see the stock gain -195.57% from current levels.
Nuvation Bio Inc (NUVB) estimates and forecasts
The company’s shares have lost -27.76% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -49.14% over the past 5 years. Earnings growth for 2025 is a modest 69.19% while over the next 5 years, the company’s earnings are expected to increase by 38.04%.
NUVB Dividends
Nuvation Bio Inc is expected to release its next earnings report on 2025-May-07 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Nuvation Bio Inc (NYSE:NUVB)’s Major holders
Insiders own 19.14% of the company shares, while shares held by institutions stand at 61.81% with a share float percentage of 76.44%. Investors are also buoyed by the number of investors in a company, with Nuvation Bio Inc having a total of 214.0 institutions that hold shares in the company. The top two institutional holders are FMR LLC with over 28.82 million shares worth more than $84.16 million. As of 2024-06-30, FMR LLC held 11.7767% of shares outstanding.
The other major institutional holder is ECOR1 CAPITAL, LLC, with the holding of over 19.21 million shares as of 2024-06-30. The firm’s total holdings are worth over $56.09 million and represent 7.8491% of shares outstanding.
